Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects

: RNAi is a powerful tool for gene silencing that can be used to reduce undesirable overexpression of oncogenes as a novel form of cancer treatment. However, when using RNAi as a therapeutic tool there is potential for associated gene effects. This study aimed to utilize gold nanoparticles to delive...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine (London, England) Vol. 10; no. 16; pp. 2513 - 2525
Main Authors Child, Hannah Winifred, Hernandez, Yulán, Conde, João, Mullin, Margaret, Baptista, Pedro, de la Fuente, Jesus Maria, Berry, Catherine Cecilia
Format Journal Article
LanguageEnglish
Published Future Medicine Ltd 01.08.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract : RNAi is a powerful tool for gene silencing that can be used to reduce undesirable overexpression of oncogenes as a novel form of cancer treatment. However, when using RNAi as a therapeutic tool there is potential for associated gene effects. This study aimed to utilize gold nanoparticles to deliver siRNA into HeLa cells. : Knockdown of the c-myc oncogene by RNAi, at the RNA, protein and cell proliferation level was achieved, while also identifying associated gene responses. : The gold nanoparticles used in this study present an excellent delivery platform for siRNA, but do note associated gene changes. : The study highlights the need to more widely assess the cell physiological response to RNAi treatment, rather than focus on the immediate RNA levels.
AbstractList : RNAi is a powerful tool for gene silencing that can be used to reduce undesirable overexpression of oncogenes as a novel form of cancer treatment. However, when using RNAi as a therapeutic tool there is potential for associated gene effects. This study aimed to utilize gold nanoparticles to deliver siRNA into HeLa cells. : Knockdown of the c-myc oncogene by RNAi, at the RNA, protein and cell proliferation level was achieved, while also identifying associated gene responses. : The gold nanoparticles used in this study present an excellent delivery platform for siRNA, but do note associated gene changes. : The study highlights the need to more widely assess the cell physiological response to RNAi treatment, rather than focus on the immediate RNA levels.
Author Hernandez, Yulán
de la Fuente, Jesus Maria
Child, Hannah Winifred
Berry, Catherine Cecilia
Conde, João
Mullin, Margaret
Baptista, Pedro
AuthorAffiliation 6Instituto de Ciencia de Materiales de Aragón (ICMA), CSIC-Universidad de Zaragoza, c/Pedro Cerbuna 12, 50009 Zaragoza, Spain
1Centre for Cell Engineering, Joseph Black Building, Glasgow University, G12 8QQ, UK
5UCIBIO, CIGMH, Departamento de Ciencias da Vida, Faculdade de Ciencias e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, Portugal
4Integrated Microscopy Facility, Joseph Black Building, Glasgow University, G12 8QQ, UK
3Massachusetts Institute of Technology, Institute for Medical Engineering & Science, Harvard-MIT Division for Health Sciences & Technology, Cambridge, MA 02139-4307, USA
2Instituto de Nanociencia de Aragón, University of Zaragoza, C/Mariano Esquillor s/n Zaragoza, Spain
AuthorAffiliation_xml – name: 4Integrated Microscopy Facility, Joseph Black Building, Glasgow University, G12 8QQ, UK
– name: 5UCIBIO, CIGMH, Departamento de Ciencias da Vida, Faculdade de Ciencias e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, Portugal
– name: 6Instituto de Ciencia de Materiales de Aragón (ICMA), CSIC-Universidad de Zaragoza, c/Pedro Cerbuna 12, 50009 Zaragoza, Spain
– name: 2Instituto de Nanociencia de Aragón, University of Zaragoza, C/Mariano Esquillor s/n Zaragoza, Spain
– name: 1Centre for Cell Engineering, Joseph Black Building, Glasgow University, G12 8QQ, UK
– name: 3Massachusetts Institute of Technology, Institute for Medical Engineering & Science, Harvard-MIT Division for Health Sciences & Technology, Cambridge, MA 02139-4307, USA
Author_xml – sequence: 1
  givenname: Hannah Winifred
  surname: Child
  fullname: Child, Hannah Winifred
– sequence: 2
  givenname: Yulán
  surname: Hernandez
  fullname: Hernandez, Yulán
– sequence: 3
  givenname: João
  surname: Conde
  fullname: Conde, João
– sequence: 4
  givenname: Margaret
  surname: Mullin
  fullname: Mullin, Margaret
– sequence: 5
  givenname: Pedro
  surname: Baptista
  fullname: Baptista, Pedro
– sequence: 6
  givenname: Jesus Maria
  surname: de la Fuente
  fullname: de la Fuente, Jesus Maria
– sequence: 7
  givenname: Catherine Cecilia
  surname: Berry
  fullname: Berry, Catherine Cecilia
BookMark eNqdj81uwjAQhK0KpPLTQ99gH6BJ7aSG5FhVLZw4VNwty960BrOLYlNevw30CTjNjDSfRjMVI2JCIR6VLKtKLZ-JDqXSZavvxEQtX5pi0S7q0cXXhW6a9l5MU9pJqZtKyYnYrTh6IEt8tH0OLmKRwufmFQ7og83ogcnxFxLCntjtPZ8JbIahYsnDseeMgSDiD8YnOIf8DTYldlf4AmLXoctpLsadjQkf_nUm9Mf79m1ddKd86jG5gOTQXNMw7wKhUdIMx8zfMaO0aXV9K_cLXeFdtg
ContentType Journal Article
Copyright Future Medicine Ltd
Copyright_xml – notice: Future Medicine Ltd
DOI 10.2217/nnm.15.95
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1748-6963
EndPage 2525
ExternalDocumentID 10_2217_nnm_15_95
GroupedDBID -
0R
123
29M
34G
39C
3V.
53G
70G
7X7
88E
8AO
8FI
8FJ
ABUWG
ACGFS
ADBBV
AENEX
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
BBAFP
BENPR
BPHCQ
BVXVI
CS3
DU5
EBS
EHMNL
F5P
FYUFA
H13
HZ
IAO
IEA
IHR
INH
INR
ITC
M1P
MV1
NTCAX
O9-
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
RFM
ID FETCH-futurescience_futuremedicine_10_2217_nnm_15_953
ISSN 1743-5889
IngestDate Tue Jan 05 21:38:03 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 16
Language English
LinkModel OpenURL
MergedId FETCHMERGED-futurescience_futuremedicine_10_2217_nnm_15_953
ParticipantIDs futurescience_futuremedicine_10_2217_nnm_15_95
ProviderPackageCode NTCAX
RFM
70G
PublicationCentury 2000
PublicationDate 2015-August-01
PublicationDateYYYYMMDD 2015-08-01
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-August-01
  day: 01
PublicationDecade 2010
PublicationTitle Nanomedicine (London, England)
PublicationYear 2015
Publisher Future Medicine Ltd
Publisher_xml – name: Future Medicine Ltd
SSID ssj0058210
Score 4.259301
Snippet : RNAi is a powerful tool for gene silencing that can be used to reduce undesirable overexpression of oncogenes as a novel form of cancer treatment. However,...
SourceID futurescience
SourceType Publisher
StartPage 2513
SubjectTerms apoptosis
c-myc
cell cycle
cell delivery
cell proliferation
gene knockdown
gold nanoparticles
knockdown
nanoparticles
off-target effects
proliferation
RNAi
siRNA
Title Gold nanoparticle-siRNA mediated oncogene knockdown at RNA and protein level, with associated gene effects
URI http://dx.doi.org/10.2217/nnm.15.95
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDI7GdgEhxFO8lQO30bJ2Tdcep2ljQmwHBNI4Ve3aiMdIJdgu_DB-H3YeXQc7MC5Vm8ZpVH9ybCe2CblocZ46YdKyvLDBLC-NPSsYB2OrkfppywXExBz9kIOh33_wbkZsVKl8lU4tzaaJPf5cGlfyH65CG_AVo2RX4GwxKDTAPfAXrsBhuP6Jx9f5JK2LWIDhq15aH893w7YKB0FVMhfjHKiz-qsAuZeCxY3Bi9hF5QfIsdZlfYIHh_Bfq0A3zTAgl6T6xEdZiwWRnJtN-aU1QUr-BZk7WS5wsRDxE4gh8cxNfVDphC05sh9nE7lz7xSQ7cDQ2s0v3zTzOUQmuti8KdZb9mA4rDg_pzDXk8lT1MYUTnt-nAkFMqZQZYEqM2Rnpi2w_FALRiPFG2W0LshkpqJd9fruMhVp_XPtcF2ZcEqIN9thtqr8-SMVNxhM2CuCPpHDopCtkZrbChkY_bVufzC8NToARh_rUFw1e5XTComvig9skE2VN2ZB15F6zf022dIGCW0rAO2QSiZ2yUYpTeUeeUGc0d84owZn1OCMFjij8ZRiF2At1TijEmeXFFFG5yijklCjbJ-wXve-07cW5hypJwO56Ncfah6QqshFdkgo98PMC0IncQLuea6XgObOQ0wXFTg89vkRsVcb-3hVghOyPsffKalO32fZGeiU0-RcM_Ab0huCrA
link.rule.ids 315,786,790,27957,27958
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gold+nanoparticle-siRNA+mediated+oncogene+knockdown+at+RNA+and+protein+level%2C+with+associated+gene+effects&rft.jtitle=Nanomedicine+%28London%2C+England%29&rft.au=Child%2C+Hannah+Winifred&rft.au=Hernandez%2C+Yul%C3%A1n&rft.au=Conde%2C+Jo%C3%A3o&rft.au=Mullin%2C+Margaret&rft.date=2015-08-01&rft.pub=Future+Medicine+Ltd&rft.issn=1743-5889&rft.eissn=1748-6963&rft.volume=10&rft.issue=16&rft.spage=2513&rft.epage=2525&rft_id=info:doi/10.2217%2Fnnm.15.95&rft.externalDocID=10_2217_nnm_15_95
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-5889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-5889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-5889&client=summon